Effect of propofol on cardiac function and gene expression after ischemic-reperfusion in isolated rat heart

Korean Journal of Anesthesiology

Volumn 58, Issue 2, 2010, Pages 153-161

  Youn, Jin Kim ^a   Hae, Ja Lim ^b   Sung, Uk Choi ^b  

^a Ewha Womans University School of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

Ischemia; Microarray; Propofol; Rat heart; Real time polymerase chain reaction; Reperfusion

Indexed keywords

ABC TRANSPORTER; BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; CASPASE 4; CASPASE 8; MESSENGER RNA; PROPOFOL; PROTEIN ABCC9; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; HEART FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART PERFORMANCE; HEART RATE; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY;

EID: 77953460044     PISSN: 20056419     EISSN: 20057563     Source Type: Journal    
DOI: 10.4097/kjae.2010.58.2.153     Document Type: Article

References (25)

1. Kloner RA, Przyklenk K, Whittaker P. Deleterious effects of oxygen radicals in ischemia/reperfusion. Resolved and unresolved issues. Circulation 1989; 80: 1115-27.
2. Maulik N, Yoshida T, Das DK. Oxidative stress developed during the reperfusion of ischemic myocardium induces apoptosis. Free Radic Biol Med 1998; 24: 869-75.
3. Mittal CK, Murad F. Activation of guanylate cyclase by superoxide dismutase and hydroxyl radical: a physiological regulator of guanosine 3′, 5′-monophosphate formation. Proc Natl Acad Sci U S A 1977; 74: 4360-4.
4. Sauer H, Rahimi G, Hescheler J, Wartenberg M. Effects of electrical fields on cardiomyocyte differentiation of embryonic stem cells. J Cell Biochem 1999; 75: 710-23.
5. Kokita N, Hara A, Abiko Y, Arakawa J, Hashizume H, Namiki A. Propofol improves functional and metabolic recovery in ischemic reperfused isolated rat hearts. Anesth Analg 1998; 86: 252-8.
6. Ko SH, Yu CW, Lee SK, Choe H, Chung MJ, Kwak YG, et al. Propofol attenuates ischemia-reperfusion injury in the isolated rat heart. Anesth Analg 1997; 85: 719-24.
7. Murphy PG, Myers DS, Davies MJ, Webster NR, Jones JG. The antioxidant potential of propofol (2,6-diisopropylphenol). Br J Anaesth 1992; 68: 613-8.
8. Kahraman S, Kilinc K, Dal D, Erdem K. Propofol attenuates formation of lipid peroxides in tourniquet-induced ischaemia-reperfusion injury. Br J Anaesth 1997; 78: 279-81.
9. Zhou W, Fontenot HJ, Liu S, Kennedy RH. Modulation of cardiac calcium channels by propofol. Anesthesiology 1997; 86: 670-5.
10. Mikawa K, Akamatsu H, Nishina K, Shiga M, Maekawa N, Obara H, et al. Propofol inhibits human neutrophil functions. Anesth Analg 1998; 87: 695-700.
11. Ebel D, Schlack W, Comfere T, Preckel B, Thamer V. Effect of propofol on reperfusion injury after regional ischaemia in the isolated rat heart. Br J Anaesth 1999; 83: 903-8.
12. Onody A, Zvara A, Hackler L Jr, Vigh L, Ferdinandy P, Puskas LG. Effect of classic Preconditioning on the gene expression pattern of rat hearts: a DNA microarray study. FEBS Lett 2003; 536: 35-40.
13. Sergeev P, da Silva R, Lucchinetti E, Zaugg K, Pasch T, Schaub MC, et al. Trigger-dependent gene expression profiles in cardiac Preconditioning: evidence for distinct genetic programs in ischemic and anesthetic preconditioning. Anesthesiology 2004; 100: 474-88.
14. Kawano T, Oshita S, Tsutsumi Y, Tomiyama Y, Kitahata H, Kuroda Y, et al. Clinically relevant concentrations of propofol have no effect on adenosine triphosphate-sensitive potassium channels in rat ventricular myocytes. Anesthesiology 2002; 96: 1472-7.
15. Mazoit JX, Samii K. Binding of propofol to blood components. implications for pharmacokinetics and for pharmacodynamics. Br J Clin Pharmacol 1999; 47: 35-42.
16. Zaugg M, Lucchinetti E, Spahn DR, Pasch T, Garcia C, Schaub MC. Differential effects of anesthetics on mitochondrial K (ATP) channel activity and cardiomyocyte protection. Anesthesiology 2002; 97: 15-23.
17. Inagaki N, Gonoi T, Seino S. Subunit stoichiometry of the pancreatic beta-cell ATP-sensitive K+ channel. FEBS Lett 1997; 409: 232-6.
18. Mizumura T, Nithipatikom K, Gross GJ. Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs. Circulation 1995; 92: 1236-45.
19. Kersten JR, Schmeling TJ, Pagel PS, Gross GJ, Warltier DC. Isoflurane mimics ischemic preconditioning via activation of K (ATP) channels. reduction of myocardial infarct size with an acute memory phase. Anesthesiology 1997; 87: 361-70.
20. ATP channels in vivo. Anesthesiology 1999; 90: 246-56.
21. Toller WG, Gross ER, Kersten JR, Pagel PS, Gross GJ, Warltier DC. Sarcolemmal and mitochondrial adenosine triphosphate-dependent potassium channels: mechanism of desflurane-induced cardioprotection. Anesthesiology 2000; 92: 1731-9.
22. Hu Y, Benedict MA, Ding L, Nüñz G. Role of cytochrome c and dATP/ATP hydrolysis in Apaf-1-mediated caspase-9 activation and apoptosis. Embo J 1999; 18: 3586-95.
23. Varfolomeev EE, Schuchmann M, Luria V, Chiannilkulchai N, Beckmann JS, Mett IL, et al. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 1998; 9: 267-76.
24. Scarabelli TM, Stephanou A, Pasini E, Comini L, Raddino R, Knight RA, et al. Different signaling pathways induce apoptosis in endothelial cells and cardiac myocytes during ischemia/ reperfusion injury. Circ Res 2002; 90: 745-8.
25. Li YY, Feldman AM, Sun Y, McTiernan CF. Differential expression of tissue inhibitors of metalloproteinases in the failing human heart. Circulation 1998; 98: 1728-34.